Literature DB >> 15208460

Update in the treatment of asthma during pregnancy.

Jennifer Altamura Namazy1, Michael Schatz.   

Abstract

Asthma is the most common potentially serious medical problem to complicate pregnancy. Recent reports suggest that 7 of every 100 pregnant women suffer from asthma during pregnancy. Asthmatic women have been shown to be at an increased risk of complications during pregnancy. This may be secondary to inadequately controlled asthma or perhaps the result of the effects of certain asthma medications taken during pregnancy. The choice to use a specific medication during pregnancy is based on available human and animal data. Much of the information currently available regarding the safety of various asthma medications during pregnancy comes from several large cohort studies. This article reviews the specific aspects of pharmacological therapy during pregnancy as provided in the recommendations of the joint ad hoc committee of the American College of Allergy Asthma and Immunology and the American College of Obstetricians and Gynecologists. This article presents practical strategies for the management of asthma in our pregnant patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208460     DOI: 10.1385/CRIAI:26:3:139

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  25 in total

1.  The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).

Authors: 
Journal:  Ann Allergy Asthma Immunol       Date:  2000-05       Impact factor: 6.347

2.  A retrospective study on the safety of immunotherapy in pregnancy.

Authors:  W A Shaikh
Journal:  Clin Exp Allergy       Date:  1993-10       Impact factor: 5.018

3.  Congenital malformations after the use of inhaled budesonide in early pregnancy.

Authors:  B Källén; H Rydhstroem; A Aberg
Journal:  Obstet Gynecol       Date:  1999-03       Impact factor: 7.661

4.  A post-marketing surveillance study of formoterol (Foradil): its use in general practice in England.

Authors:  Lynda V Wilton; Saad A Shakir
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma.

Authors:  S Schuh; D W Johnson; S Callahan; G Canny; H Levison
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

6.  The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England.

Authors:  L V Wilton; G L Pearce; R M Martin; F J Mackay; R D Mann
Journal:  Br J Obstet Gynaecol       Date:  1998-08

7.  Asthma and pregnancy: a prospective study of 198 pregnancies.

Authors:  B Stenius-Aarniala; P Piirilä; K Teramo
Journal:  Thorax       Date:  1988-01       Impact factor: 9.139

8.  Prenatal exposure to prednisone in humans and animals retards intrauterine growth.

Authors:  J M Reinisch; N G Simon; W G Karow; R Gandelman
Journal:  Science       Date:  1978-10-27       Impact factor: 47.728

9.  Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group.

Authors:  M Schatz; R S Zeiger; C P Hoffman
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

10.  The safety of immunotherapy during pregnancy.

Authors:  W J Metzger; E Turner; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1978-04       Impact factor: 10.793

View more
  3 in total

1.  Effect of pregnancy on maternal asthma symptoms and medication use.

Authors:  Kathleen Belanger; Melissa E Hellenbrand; Theodore R Holford; Michael Bracken
Journal:  Obstet Gynecol       Date:  2010-03       Impact factor: 7.661

2.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Maternal asthma medication use and the risk of gastroschisis.

Authors:  Shao Lin; Jean Pierre W Munsie; Michele L Herdt-Losavio; Erin Bell; Charlotte Druschel; Paul A Romitti; Richard Olney
Journal:  Am J Epidemiol       Date:  2008-04-23       Impact factor: 4.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.